SEER Inquiry System - Home

Welcome to the SEER Inquiry System (SINQ). SINQ is a collection of questions that cancer registrars have had while coding cancer cases. Click Search to look for specific questions or to select questions for a Report.

Recent Questions
1 to 10 of 1958    Next 10 >    Last >>
Add to Report ID Question Status Last Updated

Primary site--Other and Unspecified Urinary Organs:  What is the topography code for a Skene's gland adenocarcinoma?

Final May 23 2017

Grade--Prostate: How are the prostate-related fields completed when documentation in pathology reports only includes one of the new grade groups? See Discussion.

Final May 23 2017

MP/H Rules/Histology: What is the histology code of serous tubal intraepithelial (in situ) carcinoma (STIC), bilateral fallopian tubes?

Final May 22 2017

Grade--Appendix:   What is the code and term to use for the grade/differentiation field for well differentiated, Grade 2 neuroendocrine tumor (NET)?  See Discussion.

Final May 04 2017

MP/H Rules/Multiple primaries--Penis: How many primaries should be reported for a diagnosis of invasive squamous cell carcinoma (SCC) of the penis in 6/2011, treated with excision and fulguration followed by 10/2014 penile lesion found to be SCC with basaloid features focally highly suspicious for invasion? Clinically, the 2014 tumor is stated to be in situ and recurrent penile cancer and follow-up in 2/2015 indicates there was no evidence of tumor following treatment. Subsequently, in 3/2016 the patient has another penile lesion biopsy showing SCC in situ suspicious for invasion, clinically stated to be recurrent. See Discussion.

Final May 03 2017

Surgery Primary Site--Melanoma: How should Surgery of Primary Site be coded for a melanoma diagnosed on punch or shave biopsy followed by a wide excision that shows no residual disease and the gross wide excision specimen size showing no residual is greater than 1 cm in all dimensions (length, width and depth)?  See Discussion.

Final Apr 26 2017

Reportability--Bone: Are giant cell tumors (GCT) of the bone that metastasize to the lung reportable?  See Discussion.

Final Apr 24 2017

MP/H Rules/Histology--Kidney: How should histology be coded for a clear cell renal cell carcinoma when the CAP protocol indicates sarcomatoid features are present?  See Discussion.

Final Apr 24 2017

MP/H Rules/Multiple primaries--Melanoma: Is a melanoma with an unknown laterality a different laterality for the purposes of applying Multiple Primaries/Histology Rule M4?  See Discussion.

Final Apr 24 2017

Multiple Primaries/Histology Rules/Multiple primaries--Kidney, renal pelvis:  Are tumors diagnosed more than three years apart multiple primaries according to Rule M7 in a case with metastasis?  See Discussion.

Final Apr 24 2017
Next 10 >